Varun Kannan, MD

Gender
Male
Language
English

Primary Specialty

Neurology


Education

Medical School:
Emory University School of Medicine
Residency:
Baylor College of Medicine
Fellowship:
Baylor College of Medicine

Network


Introduction

Varun Kannan, MD, is a Pediatric Neurologist and Assistant Professor of Pediatric Neurology who specializes in neuroimmunology. He joined Children's Healthcare of Atlanta and Emory University School of Medicine in 2023, and Dr. Kannan is an integral part of the Neuroimmunology and Multiple Sclerosis (NIMS) Clinic, where he brings his expertise and passion for advancing care in pediatric neuroimmune disorders. Dr. Kannan completed his undergraduate studies at Duke University, earning degrees in biology and neuroscience. He pursued his medical education at Emory University School of Medicine before completing a residency in child neurology and a fellowship in pediatric multiple sclerosis and neuroimmunology at Baylor College of Medicine and Texas Children's Hospital.

In his current role, Dr. Kannan focuses on clinical research regarding severe and refractory forms of pediatric neuroimmune disorders. He is actively involved in medical education and serves as the site Principal Investigator or Co-Principal Investigator for several ongoing therapeutic clinical trials in this field.

Dr. Kannan is committed to enhancing pediatric neurology through research and education, and he is dedicated to improving outcomes for children with complex neuroimmune conditions.

Academic Affiliations

  • Assistant Professor of Pediatric Neurology, Emory University School of Medicine

Areas of Interest

  • Clinical research regarding severe/refractory forms of pediatric neuroimmune disorders
  • Medical education

Locations

Childrens Physician Group - Neurology

Medical Office Building at Scottish Rite, 5461 Meridian Mark Road Ste 400 Atlanta, GA 30342 Get Directions 404-785-5437

Research & Publications

Dr. Kannan is the site principal investigator or co-principal investigator for several ongoing therapeutic clinical trials in pediatric neuroimmune disorders.